Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 724743, 7 pages
doi:10.1155/2011/724743
Research Article

Psorinum Therapy in Treating Stomach, Gall Bladder, Pancreatic, and Liver Cancers: A Prospective Clinical Study

Aradeep Chatterjee,1 Jaydip Biswas,2 Ashim Chatterjee,1 Sudin Bhattacharya,2 Bishnu Mukhopadhyay,3 and Syamsundar Mandal2

1Critical Cancer Management Research Centre & Clinic, 381 S K Deb Road, West Bengal, Kolkata 700 048, India
2Chittaranjan National Cancer Institute, Kolkata 700 026, India
3National Institute of Technology, Durgapur 713209, India

Received 27 November 2009; Revised 14 October 2010; Accepted 27 October 2010

Copyright © 2011 Aradeep Chatterjee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Hutchinson and V. T. DeVita Jr., “Herceptin: HERalding a new era in breast cancer care but at what cost?” Nature Clinical Practice Oncology, vol. 2, no. 12, p. 595, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. H. Ishiguro, M. Kondo, and M. Kondo, “Economic evaluation of intensive chemotherapy with prophylactic granulocyte colony-stimulating factor for patients with high-risk early breast cancer in Japan,” Clinical Therapeutics, vol. 32, no. 2, pp. 311–326, 2010. View at Publisher · View at Google Scholar · View at PubMed
  3. G. Agarwal, P. Ramakant, E. R. Forgach, J. C. Rendón, J. M. Chaparro, C. S. Basurto, and M. Margaritoni, “Breast cancer care in developing countries,” World Journal of Surgery, vol. 33, no. 10, pp. 2069–2076, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. Sansom and G. Mutuma, “Kenya faces cancer challenge,” Lancet Oncology, vol. 3, no. 8, pp. 456–457, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Grey and A. Garces, “Cancer control in low- and middle-income countries: the role of primary care physicians,” Primary Care, vol. 36, no. 3, pp. 455–470, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. P. A. Philip, “Novel targets for pancreatic cancer therapy,” Surgical Oncology Clinics of North America, vol. 19, no. 2, pp. 419–429, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. S. Gourgiotis, H. M. Kocher, L. Solaini, A. Yarollahi, E. Tsiambas, and N. S. Salemis, “Gallbladder cancer,” American Journal of Surgery, vol. 196, no. 2, pp. 252–264, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. P. J. Wysocki, “Targeted therapy of hepatocellular cancer,” Expert Opinion on Investigational Drugs, vol. 19, no. 2, pp. 265–274, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. V. Catalano, R. Labianca, G. D. Beretta, G. Gatta, F. de Braud, and E. Van Cutsem, “Gastric cancer,” Critical Reviews in Oncology/Hematology, vol. 71, no. 2, pp. 127–164, 2009. View at Publisher · View at Google Scholar · View at PubMed
  10. D. Schiff and P. Wen, “Central nervous system toxicity from cancer therapies,” Hematology/Oncology Clinics of North America, vol. 20, no. 6, pp. 1377–1398, 2006. View at Publisher · View at Google Scholar · View at PubMed
  11. M. Theodoulou and A. D. Seidman, “Cardiac effects of adjuvant therapy for early breast cancer,” Seminars in Oncology, vol. 30, no. 6, pp. 730–739, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Vansteenkiste, E. Van Cutsem, H. Dumez, C. Chen, J. L. Ricker, S. S. Randolph, and P. Schöffski, “Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer,” Investigational New Drugs, vol. 26, no. 5, pp. 483–488, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. M. Lichtman, “Therapy insight: therapeutic challenges in the treatment of elderly cancer patients: Commentary,” Nature Clinical Practice Oncology, vol. 3, no. 2, pp. 86–93, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. T. L. Gillison and G. S. Chatta, “Cancer chemotherapy in the elderly patient,” Oncology, vol. 24, no. 1, pp. 76–85, 2010.
  15. S. Kumar and B. Mittal, “Importance of complementary and alternative cancer therapies in palliative oncology in India,” Journal of Alternative and Complementary Medicine, vol. 9, no. 6, pp. 811–812, 2003. View at Scopus
  16. S. K. Pai, “Use of alternative cancer medicine in India,” Lancet Oncology, vol. 3, no. 7, pp. 394–395, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. K. Chartterjee, S. Ganguly, S. K. Pal, A. Chatterjee, G. Mukhopadhyay, and R. Bhakta, “Attitudes of patients to alternative medicine for cancer treatment,” Asian Pacific Journal of Cancer Prevention, vol. 6, no. 2, pp. 125–129, 2005. View at Scopus
  18. A. Chatterjee, A. K. Chatterjee, J. Biswas, S. Bhattacharya, R. Chatterjee, and A. Sadhu, “Alternative cancer treatment psorinum therapy becoming persuasive to the scientific community,” in Proceedings of the World Assembly of Tobacco Counters Health, p. 44, 2007.
  19. A. Chatterjee, S. Bhattacharya, A. K. Chatterjee, J. Das, P. Chakraborty, and P. Ghosh, “Non-conventional cancer treatment Psorinum Therapy becoming persuasive to the scientific community,” in Proceedings of the The School of Life Sciences, p. 63, 2008.
  20. A. K. Chatterjee, P. K. Kundu, R. S. Bhakta, R. N. Brahmmachari, B. P. Mukherjee, and S. K. Dutta, “Non-conventional treatment of carcinoma: study of 52 cases,” Bulletin Calcutta School of Tropical Medicine, vol. 43, no. 1–4, pp. 17–20, 1995.
  21. A. K. Chatterjee, S. K. Dutta, R. S. Bhakta, A. Majumder, G. Mukherjee, and S. Ganguly, “Use of Psorinum in the treatment of cancer,” in Oral Oncology, A. K. Varma, Ed., vol. 6, pp. 297–300, Macmillan, New York, NY, USA, 1999.
  22. A. K. Chatterjee, A. Chatterjee, S. Ganguly, G. Mukhopadhyay, A. Sadhu, and S. Dutta, “The management of cancer in totality—India can take a lead [in theory and application],” in Tobacco Counters Health, A. K. Varma, Ed., vol. 4, pp. 189–192, Northern Book Centre, 2005.
  23. A. K. Chatterjee, S. K. Dutta, S. K. Ganguly, A. Majumder, S. Mukhopadhyay, and R. S. Bhakta, “Psorinum makes a major break through in the treatment of tobacco related lung cancer,” in Tobacco Counters Health, A. K. Varma, Ed., vol. 2, pp. 197–203, Macmillan, New York, NY, USA, 2002.
  24. A. K. Chatterjee, S. K. Ganguly, G. Mukhopadhyay, A. Mukherjee, A. Majumder, and J. Biswas, “Non-conventional treatment of tobacco related cancer gradually gets right prespective through psorinum therapy,” in Tobacco Counters Health, A. K. Varma, Ed., vol. 3, pp. 159–166, Macmillan, New York, NY, USA, 2004.
  25. A. K. Chatterjee and A. Chatterjee, “Treatment of oral, lung, liver, gall bladder, pancreatic and stomach cancers through alternative cancer treatment psorinum therapy,” in Proceedings of the Office of Cancer Complementary and Alternative Medicine of NCI—Cancer Researcher and CAM Practitioner Fostering Collaboration, Advancing the Science, 2007.
  26. A. Chatterjee, A. K. Chatterjee, J. Biswas, S. Bhattacharya, R. Chatterjee, and A. Sadhu, “Psorinum Therapy makes a major break through in the treatment of oral, lung, liver, gall bladder, pancreatic and stomach cancers,” in Proceedings of the Chittaranjan National Cancer Institute (CNCI) Golden Jubilee Celebration—Recent Trends in Cancer Research and Treatment, pp. 67–68, 2007.
  27. A. Chatterjee, S. Bhattacharya, A. K. Chatterjee, J. Biswas, et al., “A Phase-II single armed clinical trial involving an alternative cancer treatment Psorinum Therapy in treating non small cell ling carcinoma (NSCLC),” in Proceedings of the The School of Life Sciences, JNU—Cancer Chemoprevention and Translational Research, p. 17, 2009.
  28. A. Chatterjee, J. Biswas, A. K. Chatterjee, S. Bhattacharya, and B. P. Mukopadhyay, “A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with non small cell lung carcinoma (NSCLC),” Journal of Clinical Oncology, vol. 28, supplement, p. 15s, 2010, abstract 2592.
  29. A. Chatterjee, S. Bhattacharya, A. K. Chatterjee, J. Biswas, and B. P. Mukhopadhyay, “A prospective observational clinical study involving an alternative cancer treatment, psorinum therapy, in treating stomach, gall bladder, pancreas and liver cancers,” Journal of Clinical Oncology, vol. 27, supplement, p. 15s, 2009, abstract 3050.
  30. E. S. Rajendran, “Homeopathy as a supportive therapy in cancer,” Homeopathy, vol. 93, no. 2, pp. 99–102, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Ernst, “Complementary therapies in palliative cancer care,” Cancer, vol. 91, no. 11, pp. 2181–2185, 2001. View at Scopus
  32. P. Tiemann, M. Toelg, and M. H. Ramos F., “Administration of Ratanhia-based herbal oral care products for the prophylaxis of oral mucositis in cancer chemotherapy patients: a clinical trial,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 3, pp. 361–366, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. N. Aghabati, E. Mohammadi, and Z. Pour Esmaiel, “The effect of therapeutic touch on pain and fatigue of cancer patients undergoing chemotherapy,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 3, pp. 375–381, 2010. View at Publisher · View at Google Scholar · View at PubMed
  34. M.-L. Liu, L.-Y. Chien, C.-J. Tai, K.-C. Lin, and C.-J. Tai, “Effectiveness of traditional chinese medicine for liver protection and chemotherapy completion among cancer patients,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar · View at PubMed
  35. J. Z. Liu, S. G. Chen, B. Zhang, C. B. Wang, X. W. Zhao, G. Y. Li, and L. X. Wang, “Effect of haishengsu as an adjunct therapy for patients with advanced renal cell cancer: a randomized and placebo-controlled clinical trial,” Journal of Alternative and Complementary Medicine, vol. 15, no. 10, pp. 1127–1130, 2009.